IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 222 filers reported holding IMMUNOGEN INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $222,180 | -15.9% | 14,000 | 0.0% | 0.14% | -12.3% |
| Q2 2023 | $264,180 | +209.2% | 14,000 | -37.1% | 0.15% | +180.0% |
| Q1 2023 | $85,440 | -22.6% | 22,250 | 0.0% | 0.06% | -32.9% |
| Q4 2022 | $110,360 | +4.1% | 22,250 | 0.0% | 0.08% | +5.1% |
| Q3 2022 | $106,000 | +6.0% | 22,250 | 0.0% | 0.08% | +11.4% |
| Q2 2022 | $100,000 | -5.7% | 22,250 | 0.0% | 0.07% | +12.9% |
| Q1 2022 | $106,000 | -35.8% | 22,250 | 0.0% | 0.06% | -31.9% |
| Q4 2021 | $165,000 | +31.0% | 22,250 | 0.0% | 0.09% | +21.3% |
| Q3 2021 | $126,000 | -14.3% | 22,250 | 0.0% | 0.08% | -15.7% |
| Q2 2021 | $147,000 | -18.3% | 22,250 | 0.0% | 0.09% | -25.8% |
| Q1 2021 | $180,000 | +20.0% | 22,250 | -4.3% | 0.12% | +11.1% |
| Q4 2020 | $150,000 | +78.6% | 23,250 | 0.0% | 0.11% | +56.5% |
| Q3 2020 | $84,000 | -21.5% | 23,250 | 0.0% | 0.07% | -31.0% |
| Q2 2020 | $107,000 | +35.4% | 23,250 | 0.0% | 0.10% | +8.7% |
| Q1 2020 | $79,000 | -33.6% | 23,250 | 0.0% | 0.09% | -17.9% |
| Q4 2019 | $119,000 | – | 23,250 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |